Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 2/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | TNF | P01375 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19238240 | 1.00 | CYP17A1 (0.34) | CYP17A1CYP1A2KDM4EATML3MBTL1 | |
| SCHEMBL19238242 | 0.95 | KDM4E (0.38) | CYP17A1CYP1A2KDM4EATML3MBTL1 | |
| SCHEMBL19238251 | 0.95 | KDM4E (0.38) | CYP17A1CYP1A2KDM4EATML3MBTL1 | |
| SCHEMBL19238253 | 0.95 | PIK3CA (0.36) | CYP17A1CYP1A2ATML3MBTL1TSPO | |
| SCHEMBL19238239 | 0.95 | PIK3CA (0.36) | CYP17A1CYP1A2ATML3MBTL1TSPO | |
| SCHEMBL19238258 | 0.92 | KDM4E (0.36) | CYP17A1CYP1A2KDM4EATML3MBTL1 | |
| SCHEMBL19238245 | 0.92 | KDM4E (0.36) | CYP17A1CYP1A2KDM4EATML3MBTL1 | |
| SCHEMBL19238244 | 0.92 | KDM4E (0.36) | CYP17A1CYP1A2KDM4EATML3MBTL1 | |
| SCHEMBL19238260 | 0.92 | KDM4E (0.36) | CYP17A1CYP1A2KDM4EATML3MBTL1 | |
| SCHEMBL19243413 | 0.92 | KDM4E (0.32) | CYP17A1CYP1A2KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10629821-B2 | Compound, material for organic electroluminescent elements using same, and organic electroluminescent element and electronic device each using same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-21 | — | — | US | disclosed |
| US-20170237016-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EACH USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-17 | — | — | US | disclosed |
| US-20170237016-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EACH USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170237016-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EACH USING SAME | OR10J3, LEF1, PIEZO1 | CYP17A1 3154/4885CYP1A2 2636/4885KDM4E 536/4885 |
| US-10629821-B2 | Compound, material for organic electroluminescent elements using same, and organic electroluminescent element and electronic device each using same | OR10J3, LEF1, PIEZO1 | CYP17A1 3154/4885CYP1A2 2636/4885KDM4E 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.